Dana-Farber
Genomic Study Reveals Rearrangements Behind Female-Predominant Kidney Cancer
Researchers scoured dozens of tumor genome sequences to identify roles for active and inactive X chromosome sequences in Xp11 translocation renal cell carcinoma.
Genome Sequencing Adds 8 Percent to Diagnostic Yield for Rare Diseases Over Other Genetic Tests
Researchers found that genome sequencing uncovered several types of pathogenic variants that had eluded exome sequencing and other types of genetic tests.
Childhood Leukemia Study Leads to Ancient Variant Linked to Population-Specific Risk
Researchers tracked enhanced acute lymphoblastic leukemia rates in Hispanic/Latino ancestry children to a variant inherited from ancient Indigenous American ancestors.
The NEMO assay detects aggressive neuroendocrine prostate cancer early in its evolution, potentially enabling treatment before resistance arises.
Multiple Myeloma Research Foundation Awards $21M in Research Grants
The grants will support research using omics and other technologies to study and treat different forms of multiple myeloma including high-risk disease.